Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Guardado en:

Detalles Bibliográficos
Autores principales:	Maria del Carmen Asensio Lopez, Antonio Lax, Alvaro Hernandez Vicente, Elena Saura Guillen, Antonio Hernandez-Martinez, Maria Josefa Fernandez del Palacio, Antoni Bayes-Genis, Domingo A. Pascual Figal
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/d7ab907b9e24426b99920de473b0d348
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d7ab907b9e24426b99920de473b0d348
record_format	dspace
spelling	oai:doaj.org-article:d7ab907b9e24426b99920de473b0d3482021-12-02T18:37:07ZAuthor Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status10.1038/s41598-020-73065-52045-2322https://doaj.org/article/d7ab907b9e24426b99920de473b0d3482020-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-73065-5https://doaj.org/toc/2045-2322An amendment to this paper has been published and can be accessed via a link at the top of the paper.Maria del Carmen Asensio LopezAntonio LaxAlvaro Hernandez VicenteElena Saura GuillenAntonio Hernandez-MartinezMaria Josefa Fernandez del PalacioAntoni Bayes-GenisDomingo A. Pascual FigalNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-1 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Maria del Carmen Asensio Lopez Antonio Lax Alvaro Hernandez Vicente Elena Saura Guillen Antonio Hernandez-Martinez Maria Josefa Fernandez del Palacio Antoni Bayes-Genis Domingo A. Pascual Figal Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
description	An amendment to this paper has been published and can be accessed via a link at the top of the paper.
format	article
author	Maria del Carmen Asensio Lopez Antonio Lax Alvaro Hernandez Vicente Elena Saura Guillen Antonio Hernandez-Martinez Maria Josefa Fernandez del Palacio Antoni Bayes-Genis Domingo A. Pascual Figal
author_facet	Maria del Carmen Asensio Lopez Antonio Lax Alvaro Hernandez Vicente Elena Saura Guillen Antonio Hernandez-Martinez Maria Josefa Fernandez del Palacio Antoni Bayes-Genis Domingo A. Pascual Figal
author_sort	Maria del Carmen Asensio Lopez
title	Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
title_short	Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
title_full	Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
title_fullStr	Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
title_full_unstemmed	Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
title_sort	author correction: empagliflozin improves post-infarction cardiac remodeling through gtp enzyme cyclohydrolase 1 and irrespective of diabetes status
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/d7ab907b9e24426b99920de473b0d348
work_keys_str_mv	AT mariadelcarmenasensiolopez authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT antoniolax authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT alvarohernandezvicente authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT elenasauraguillen authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT antoniohernandezmartinez authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT mariajosefafernandezdelpalacio authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT antonibayesgenis authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT domingoapascualfigal authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus
_version_	1718377829651972096

Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status

Ejemplares similares